{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:06Z","timestamp":1792108806900,"version":"4.4.0"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Intradetrusor onabotulinumtoxinA injection is an effective advanced treatment for overactive bladder. While the effective dosages have been well studied, very little data exist on treatment efficacy using differing injection techniques. The objective of this study was to determine whether the efficacy of a reduced injection technique of 5 injection sites was noninferior to the standard technique of 20 injection sites of intradetrusor onabotulinumtoxinA for treatment of overactive bladder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized noninferiority trial, men and women seeking treatment of overactive bladder with intradetrusor onabotulinumtoxinA injections were randomized to receive 100 units administered via either a reduced injection technique of 5 injection sites or a standard injection technique of 20 injection sites. Subjects completed a series of standardized questionnaires at baseline and at 4\u201312 weeks postprocedure to determine symptom severity and treatment efficacy. The primary outcome was treatment efficacy as determined by Overactive Bladder Questionnaire\u2010Short Form with a noninferiority margin of 15 points. Secondary outcomes were incidence of urinary tract infection and urinary retention requiring catheterization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data from 77 subjects were available for analysis with 39 in the control arm (20 injections) and 38 in the study arm (5 injections). There was a significant improvement in both arms from baseline to follow\u2010up in Overactive Bladder Questionnaire\u2010Short Form and International Consultation on Incontinence Questionnaire scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Overall treatment success was 68% with no statistically significant difference between arms. A significant difference between arms was found on the Overactive Bladder Questionnaire\u2010Short Form quality of life survey favoring the control arm (confidence interval [CI]: 0.36\u201320.5,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). However, there were no significant differences between arms in the remaining validated questionnaires. The study arm did not demonstrate noninferiority to the control arm. Subjects in the study arm were significantly more likely to express a willingness to undergo the procedure again (odds ratio\u2009=\u20093.8, 95% CI: 1.42\u201310.67,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). Adverse events did not differ between arms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A reduced injection technique for administration of intradetrusor onabotulinumtoxinA demonstrates similar efficacy to the standard injection technique but did not demonstrate noninferiority. Subjects preferred the reduced injection technique over the standard technique. A reduced injection technique is a safe and effective alternative to the standard technique.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/nau.25107","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T20:41:56Z","timestamp":1669927316000},"page":"366-374","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder"],"prefix":"10.1002","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-6672","authenticated-orcid":false,"given":"Angela M.","family":"DiCarlo\u2010Meacham","sequence":"first","affiliation":[{"name":"Department of Gynecologic Surgery and Obstetrics Naval Medical Center San Diego San Diego California USA"},{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Dengler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva K.","family":"Welch","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Research Programs Walter Reed National Military Medical Center Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"},{"name":"Department of Urogynecology Sibley Memorial Hospital  Washington District of Columbia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Osborn","sequence":"additional","affiliation":[{"name":"Department of Urology Walter Reed National Military Medical Center Bethesda Maryland USA"},{"name":"Department of Urology Chesapeake Urology Associates  Germantown Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Scarlotta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"},{"name":"Department of Obstetrics and Gynecology General Leonard Wood Army Hospital  Fort Leonard Wood Missouri USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Walter Reed National Military Medical Center Bethesda Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,12]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.2001.02228.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11884-016-0344-9"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-017-0216-4"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-008-0600-9"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12253"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.10.026"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.12.022"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.04.001"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.12.056"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.08.021"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208872"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.10.013"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.14617"},{"key":"e_1_2_8_15_1","unstructured":"Botox [package insert].Irvine CA: Allergan Inc.2018."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22533"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000020026"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016370925601"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22559"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20110"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.379"},{"key":"e_1_2_8_22_1","unstructured":"AbramsP CardozoL WaggA WeinA. (Eds) Incontinence6 edition(2017). ICI\u2010ICS. th International Continence Society Bristol UK. Chapter 5B. Patient reported outcome assessment 541\u2010598."},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2006.03.088"},{"key":"e_1_2_8_24_1","first-page":"5947153","article-title":"Intravesicular onabotulinumtoxinA hemorrhage on rivaroxaban","volume":"2019","author":"Eubanks A","year":"2019","journal-title":"Case Rep Obstet Gynecol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22780"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/nau.23052"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.25107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/nau.25107","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.25107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:19:31Z","timestamp":1692569971000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.25107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/nau.25107"],"URL":"https:\/\/doi.org\/10.1002\/nau.25107","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2022-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}